Doença de Lyme

Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice puidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.Texto completo  Resumo

Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis. 2003 Aug;3(8):489-500. Resumo

Steere AC. Lyme disease. N Engl J Med. 2001 Jul 12;345(2):115-25. Resumo

Stanek G, Strle F. Lyme borreliosis. Lancet. 2003 Nov 15;362(9396):1639-47. Resumo

Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004 Apr;113(8):1093-101.Texto completo  Resumo

Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005 Jul;18(3):484-509.Texto completo  Resumo

Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect. 2004;10:598-614. Resumo

Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med. 2003 Jun 12;348(24):2424-30. Resumo

Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1.Texto completo  Resumo

National Institute for Health and Care Excellence (UK). Lyme disease. October 2018 [internet publication].Texto completo

1. Tibbles CD, Edlow JA. Does this patient have erythema migrans? JAMA. 2007 Jun 20;297(23):2617-27. Resumo

2. Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice puidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis and treatment of Lyme disease. Clin Infect Dis. 2021 Jan 23;72(1):e1-48.Texto completo  Resumo

3. Hengge UR, Tannapfel A, Tyring SK, et al. Lyme borreliosis. Lancet Infect Dis. 2003 Aug;3(8):489-500. Resumo

4. Steere AC. Lyme disease. N Engl J Med. 2001 Jul 12;345(2):115-25. Resumo

5. Nau R, Christen HJ, Eiffert H. Lyme disease: current state of knowledge. Dtsch Arztebl Int. 2009 Jan;106(5):72-81;quiz 82, I.Texto completo  Resumo

6. Schwartz AM, Hinckley AF, Mead PS, et al. Surveillance for Lyme disease - United States, 2008-2015. MMWR Surveill Summ. 2017 Nov 10;66(22):1-12.Texto completo  Resumo

7. Stanek G, Strle F. Lyme borreliosis. Lancet. 2003 Nov 15;362(9396):1639-47. Resumo

8. Bennet L, Halling A, Berglund J. Increased incidence of Lyme borreliosis in southern Sweden following mild winters and during warm, humid summers. Eur J Clin Microbiol Infect Dis. 2006 Jul;25(7):426-32. Resumo

9. Centers for Disease Control and Prevention. Tickborne disease surveillance data summary. November 2019 [internet publication].Texto completo

10. Centers for Disease Control and Prevention. How many people get Lyme disease? December 2018 [internet publication].Texto completo

11. Adams DA, Thomas KR, Jajosky RA, et al. Summary of notifiable infectious diseases and conditions - United States, 2015. MMWR Morb Mortal Wkly Rep. 2017 Aug 11;64(53):1-143.Texto completo  Resumo

12. Zhang X, Meltzer MI, Pena CA, et al. Economic impact of Lyme disease. Emerg Infect Dis. 2006 Apr;12(4):653-60.Texto completo  Resumo

13. Groseclose SL, Brathwaite WS, Hall PA, et al. Summary of notifiable diseases - United States, 2002. MMWR Morb Mortal Wkly Rep. 2004 Apr 30;51(53):1-84.Texto completo  Resumo

14. Steere AC, McHugh G, Suarez C, et al. Prospective study of coinfection in patients with erythema migrans. Clin Infect Dis. 2003 Apr 15;36(8):1078-81.Texto completo  Resumo

15. Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J Clin Invest. 2004 Apr;113(8):1093-101.Texto completo  Resumo

16. Aguero-Rosenfeld ME, Wang G, Schwartz I, et al. Diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2005 Jul;18(3):484-509.Texto completo  Resumo

17. Pritt BS, Mead PS, Johnson DK, et al. Identification of a novel pathogenic Borrelia species causing Lyme borreliosis with unusually high spirochaetaemia: a descriptive study. Lancet Infect Dis. 2016 May;16(5):556-64.Texto completo  Resumo

18. Singh SK, Girschick HJ. Lyme borreliosis: from infection to autoimmunity. Clin Microbiol Infect. 2004;10:598-614. Resumo

19. Hayes EB, Piesman J. How can we prevent Lyme disease? N Engl J Med. 2003 Jun 12;348(24):2424-30. Resumo

20. Daltroy LH, Phillips C, Lew R, et al. A controlled trial of a novel primary prevention program for Lyme disease and other tick-borne illnesses. Health Educ Behav. 2007 Jun;34(3):531-42. Resumo

21. Bratton RL, Whiteside JW, Hovan MJ, et al. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008 May;83(5):566-71.Texto completo  Resumo

22. Dessau RB, van Dam AP, Fingerle V, et al. To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis. Clin Microbiol Infect. 2018 Feb;24(2):118-24.Texto completo  Resumo

23. Centers for Disease Control and Prevention. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep. 1995 Aug 11;44(31):590-1.Texto completo  Resumo

24. Mead P, Petersen J, Hinckley A. Updated CDC recommendation for serologic diagnosis of lyme disease. MMWR Morb Mortal Wkly Rep. 2019 Aug 16;68(32):703.Texto completo  Resumo

25. National Institute for Health and Care Excellence (UK). Lyme disease. October 2018 [internet publication].Texto completo

26. Mygland A, Ljøstad U, Fingerle V, et al; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010 Jan;17(1):8-16;e1-4.Texto completo  Resumo

27. Moore A, Nelson C, Molins C, et al. Current guidelines, common clinical pitfalls, and future directions for laboratory diagnosis of Lyme disease, United States. Emerg Infect Dis. 2016 Jul;22(7):1169–77.Texto completo  Resumo

28. Branda JA, Steere AC. Laboratory diagnosis of Lyme borreliosis. Clin Microbiol Rev. 2021 Jan 27 [Epub ahead of print]. Resumo

29. American Academy of Pediatrics. Lyme disease. In: Kimberlin DW, Brady MT, Jackson MA, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018: 515-23.

30. American Academy of Pediatrics. Tetracyclines. In: Kimberlin DW, Brady MT, Jackson MA, eds. Red Book: 2018 Report of the Committee on Infectious Diseases. 31st ed. Itasca, IL: American Academy of Pediatrics; 2018: 905-6.

31. Steere AC, Malawista SE, Newman JH, et al. Antibiotic therapy in Lyme disease. Ann Intern Med. 1980 Jul;93(1):1-8. Resumo

32. Steere AC, Hutchinson GJ, Rahn DW, et al. Treatment of early manifestations of Lyme disease. Ann Intern Med. 1983 Jul;99(1):22-6. Resumo

33. Massarotti EM, Luger SW, Rahn DW, et al. Treatment of early Lyme disease. Am J Med. 1992 Apr;92(4):396-403. Resumo

34. Nadelman RB, Luger SW, Frank E, et al. Comparison of cefuroxime axetil and doxycycline in the treatment of early Lyme disease. Ann Intern Med. 1992 Aug 15;117(4):273-80. Resumo

35. Luger SW, Paparone P, Wormser GP, et al. Comparison of cefuroxime axetil and doxycycline in treatment of patients with early Lyme disease associated with erythema migrans. Antimicrob Agents Chemother. 1995 Mar;39(3):661-7.Texto completo  Resumo

36. Nowakowski J, Nadelman RB, Forseter G, et al. Doxycycline versus tetracycline therapy for Lyme disease associated with erythema migrans. J Am Acad Dermatol. 1995 Feb;32(2 Pt 1):223-7. Resumo

37. Eppes SC, Childs JA. Comparative study of cefuroxime axetil versus amoxicillin in children with early Lyme disease. Pediatrics. 2002 Jun;109(6):1173-7. Resumo

38. Wormser GP, Ramanathan R, Nowakowski J, et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 2003 May 6;138(9):697-704. Resumo

39. Sigal LH. Early disseminated Lyme disease: cardiac manifestations. Am J Med. 1995 Apr 24;98(4A):25S-28S;discussion 28S-29S. Resumo

40. Berende A, Ter Hofstede HJM, Vos FJ, et al. Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis. Neurology. 2019 Mar 26;92(13):e1447-55.Texto completo  Resumo

41. Waddell LA, Greig J, Lindsay LR, et al. A systematic review on the impact of gestational Lyme disease in humans on the fetus and newborn. PLoS One. 2018 Nov 12;13(11):e0207067.Texto completo  Resumo

42. Lathrop SL, Ball R, Haber P, et al. Adverse event reports following vaccination for Lyme disease: December 1998-July 2000. Vaccine. 2002 Feb 22;20(11-12):1603-8. Resumo

43. Nadelman RB, Nowakowski J, Fish D, et al; Tick Bite Study Group. Prophylaxis with single-dose doxycycline for the prevention of Lyme disease after an Ixodes scapularis tick bite. N Engl J Med. 2001 Jul 12;345(2):79-84.Texto completo  Resumo

44. Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum. 1994 Jun;37(6):878-88. Resumo

45. Eckman MH, Steere AC, Kalish RA, et al. Cost effectiveness of oral as compared with intravenous antibiotic treatment for patients with early Lyme disease or Lyme arthritis. N Engl J Med. 1997 Jul 31;337(5):357-63.Texto completo  Resumo

46. Nemeth J, Bernasconi E, Heininger U, et al. Update of the Swiss guidelines on post-treatment Lyme disease syndrome. Swiss Med Wkly. 2016 Dec 5;146:w14353.Texto completo  Resumo

47. Eliassen KE, Hjetland R, Reiso H, et al. Symptom load and general function among patients with erythema migrans: a prospective study with a 1-year follow-up after antibiotic treatment in Norwegian general practice. Scand J Prim Health Care. 2017 Mar;35(1):75-83.Texto completo  Resumo

48. Berende A, ter Hofstede HJ, Vos FJ, et al. Randomized trial of longer-term therapy for symptoms attributed to Lyme disease. N Engl J Med. 2016;374:1209-1220.Texto completo  Resumo

49. Steere AC, Pachner AR, Malawista SE. Neurologic abnormalities of Lyme disease: successful treatment with high-dose intravenous penicillin. AAnn Intern Med. 1983 Dec;99(6):767-72. Resumo

50. Dotevall L, Alestig K, Hanner P, et al. The use of doxycycline in nervous system Borrelia burgdorferi infection. Scand J Infect Dis Suppl. 1988;53:74-9. Resumo

51. Pfister HW, Preac-Mursic V, Wilske B, et al. Cefotaxime vs. penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. Arch Neurol. 1989 Nov;46(11):1190-4. Resumo

52. Mullegger RR, Millner MM, Stanek G, et al. Penicillin G sodium and ceftriaxone in the treatment of neuroborreliosis in children - a prospective study. Infection. 1991 Jul-Aug;19(4):279-83. Resumo

53. Pfister HW, Preac-Mursic V, Wilske B, et al. Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis. J Infect Dis. 1991 Feb;163(2):311-8. Resumo

54. Wormser GP. Treatment and prevention of Lyme disease, with emphasis on antimicrobial therapy for neuroborreliosis and vaccination. Semin Neurol. 1997 Mar;17(1):45-52. Resumo

55. Dotevall L, Hagberg L. Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis. 1999 Mar;28(3):569-74.Texto completo  Resumo

56. Karlsson M, Hammers-Berggren S, Lindquist L, et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis. Neurology. 1994 Jul;44(7):1203-7. Resumo

57. Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme borreliosis: randomized comparison of doxycycline and penicillin G. J Neurol. 1989 Dec;236(8):464-9. Resumo

58. Thorstrand C, Belfrage E, Bennet R, et al. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J. 2002 Dec;21(12):1142-5. Resumo

59. Borg R, Dotevall L, Hagberg L, et al. Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis. Scand J Infect Dis. 2005;37(6-7):449-54. Resumo

60. Karkkonen K, Stiernstedt SH, Karlsson M. Follow-up of patients treated with oral doxycycline for Lyme borreliosis. Scand J Infect Dis. 2001;33(4):259-62. Resumo

61. Dattwyler RJ, Halperin JJ, Volkman DJ, et al. Treatment of late Lyme borreliosis - randomized comparison of ceftriaxone and penicillin. Lancet. 1988 May 28;1(8596):1191-4. Resumo

62. Dattwyler RJ, Wormser GP, Rush TJ, et al. A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr. 2005 Jun;117(11-12):393-7. Resumo

63. Pinto DS. Cardiac manifestations of Lyme disease. Med Clin North Am. 2002 Mar;86(2):285-96. Resumo

64. Strle F, Maraspin V, Pleterski-Rigler D, et al. Treatment of borrelial lymphocytoma. Infection. 1996 Jan-Feb;24(1):80-4. Resumo

65. Marzec NS, Nelson C, Waldron PR, et al. Serious bacterial infections acquired during treatment of patients given a diagnosis of chronic Lyme disease - United States. MMWR Morb Mortal Wkly Rep. 2017 Jun 16;66(23):607-9.Texto completo  Resumo